Biodesix Stock Performance
| BDSX Stock | USD 10.40 0.47 4.73% |
On a scale of 0 to 100, Biodesix holds a performance score of 6. The firm shows a Beta (market volatility) of 0.3, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biodesix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biodesix is expected to be smaller as well. Please check Biodesix's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Biodesix's price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biodesix are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Biodesix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 4.73 | Five Day Return 2.97 | Year To Date Return 60.99 | Ten Year Return (95.94) | All Time Return (95.94) |
Last Split Factor 1:20 | Last Split Date 2025-09-15 |
1 | Disposition of tradable shares by Gary Pestano of Biodesix at 7.62 subject to Rule 16b-3 | 11/13/2025 |
2 | Biodesix Jumps 46 percent As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN | 12/15/2025 |
3 | Acquisition by Vazquez Chris of 12000 shares of Biodesix at 6.46 subject to Rule 16b-3 | 01/02/2026 |
4 | Disposition of 1143 shares by Patience John of Biodesix subject to Rule 16b-3 | 01/05/2026 |
5 | Will Biodesix Inc. stock benefit from automation - July 2025 Trends Weekly Top Performers Watchlists - ulpravda.ru | 01/08/2026 |
6 | Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results | 01/12/2026 |
7 | Investors Still Arent Entirely Convinced By Biodesix, Inc.s Revenues Despite 26 percent Price Jump | 01/14/2026 |
8 | Acquisition by Vazquez Chris of 219 shares of Biodesix subject to Rule 16b-3 | 01/20/2026 |
9 | Acquisition by Schuler Jack W of 82465 shares of Biodesix at 10.9569 subject to Rule 16b-3 | 01/22/2026 |
10 | Acquisition by Schuler Jack W of 80000 shares of Biodesix at 11.8084 subject to Rule 16b-3 | 01/23/2026 |
11 | Perkins Capital Management Inc. Sells 1,007,078 Shares of Biodesix, Inc. BDSX | 01/26/2026 |
12 | Can Biodesix Sustain Its Growth Momentum In 2026 - RTTNews | 02/03/2026 |
| Begin Period Cash Flow | 26.4 M | |
| Total Cashflows From Investing Activities | -3.4 M |
Biodesix Relative Risk vs. Return Landscape
If you would invest 795.00 in Biodesix on November 12, 2025 and sell it today you would earn a total of 245.00 from holding Biodesix or generate 30.82% return on investment over 90 days. Biodesix is currently generating 0.8017% in daily expected returns and assumes 9.1348% risk (volatility on return distribution) over the 90 days horizon. In different words, 82% of stocks are less volatile than Biodesix, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biodesix Target Price Odds to finish over Current Price
The tendency of Biodesix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.40 | 90 days | 10.40 | about 6.94 |
Based on a normal probability distribution, the odds of Biodesix to move above the current price in 90 days from now is about 6.94 (This Biodesix probability density function shows the probability of Biodesix Stock to fall within a particular range of prices over 90 days) .
Biodesix Price Density |
| Price |
Predictive Modules for Biodesix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biodesix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biodesix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biodesix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biodesix is not an exception. The market had few large corrections towards the Biodesix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biodesix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biodesix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.60 | |
β | Beta against Dow Jones | 0.30 | |
σ | Overall volatility | 1.50 | |
Ir | Information ratio | 0.06 |
Biodesix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biodesix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biodesix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biodesix is way too risky over 90 days horizon | |
| Biodesix appears to be risky and price may revert if volatility continues | |
| Biodesix has high likelihood to experience some financial distress in the next 2 years | |
| Biodesix currently holds 61.98 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 71.32 M. Net Loss for the year was (42.93 M) with profit before overhead, payroll, taxes, and interest of 63.99 M. | |
| Biodesix currently holds about 15.18 M in cash with (48.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Biodesix has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of Biodesix shares are held by company insiders | |
| Latest headline from news.google.com: Can Biodesix Sustain Its Growth Momentum In 2026 - RTTNews |
Biodesix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biodesix Stock often depends not only on the future outlook of the current and potential Biodesix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biodesix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.5 M | |
| Cash And Short Term Investments | 26.2 M |
Biodesix Fundamentals Growth
Biodesix Stock prices reflect investors' perceptions of the future prospects and financial health of Biodesix, and Biodesix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biodesix Stock performance.
| Return On Equity | -3.03 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (0.32) % | ||||
| Current Valuation | 135.88 M | ||||
| Shares Outstanding | 7.96 M | ||||
| Price To Book | 54.13 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 71.32 M | ||||
| Gross Profit | 63.99 M | ||||
| EBITDA | (29.22 M) | ||||
| Net Income | (42.93 M) | ||||
| Cash And Equivalents | 15.18 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 61.98 M | ||||
| Debt To Equity | 3.20 % | ||||
| Current Ratio | 0.64 X | ||||
| Book Value Per Share | (0.22) X | ||||
| Cash Flow From Operations | (48.65 M) | ||||
| Earnings Per Share | (5.23) X | ||||
| Market Capitalization | 79.44 M | ||||
| Total Asset | 97.24 M | ||||
| Retained Earnings | (462.5 M) | ||||
| Working Capital | 25.17 M | ||||
About Biodesix Performance
Evaluating Biodesix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biodesix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biodesix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 45.17 | 49.36 | |
| Return On Tangible Assets | (0.51) | (0.53) | |
| Return On Capital Employed | (0.37) | (0.39) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (2.36) | (2.48) |
Things to note about Biodesix performance evaluation
Checking the ongoing alerts about Biodesix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biodesix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biodesix is way too risky over 90 days horizon | |
| Biodesix appears to be risky and price may revert if volatility continues | |
| Biodesix has high likelihood to experience some financial distress in the next 2 years | |
| Biodesix currently holds 61.98 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 71.32 M. Net Loss for the year was (42.93 M) with profit before overhead, payroll, taxes, and interest of 63.99 M. | |
| Biodesix currently holds about 15.18 M in cash with (48.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Biodesix has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of Biodesix shares are held by company insiders | |
| Latest headline from news.google.com: Can Biodesix Sustain Its Growth Momentum In 2026 - RTTNews |
- Analyzing Biodesix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biodesix's stock is overvalued or undervalued compared to its peers.
- Examining Biodesix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biodesix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biodesix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biodesix's stock. These opinions can provide insight into Biodesix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.